BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diao L, Shen A, Yang Y, Tao J, Hu Y. CD44-targeted hyaluronic acid–curcumin reverses chemotherapeutics resistance by inhibiting P-gp and anti-apoptotic pathways. RSC Adv 2019;9:40873-82. [DOI: 10.1039/c9ra08202f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Dhilip Kumar SS, Abrahamse H. Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy. Front Chem 2022;10:969809. [DOI: 10.3389/fchem.2022.969809] [Reference Citation Analysis]
2 Alghaith AF, Mahrous GM, Alqahtani AS, Nasr FA, Alotaibi TS, Radwan AA. Enhancement of the dissolution and in-vitro activity of a new antineoplastic agent. Pharm Dev Technol 2021;:1-34. [PMID: 34806524 DOI: 10.1080/10837450.2021.2008966] [Reference Citation Analysis]
3 Taghipour-sabzevar V, Sharifi T, Bagheri-khoulenjani S, Goodarzi V, Kooshki H, Halabian R, Moosazadeh Moghaddam M. Targeted delivery of a short antimicrobial peptide against CD44-overexpressing tumor cells using hyaluronic acid-coated chitosan nanoparticles: An in vitro study. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-04838-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]